Literature DB >> 23872655

How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient?

Scott M Lilly1, Jack Rome, Saif Anwaruddin, Satya Shreenivas, Nimesh Desai, Frank E Silvestry, Howard C Herrmann, Amir Fassa, Dominique Himbert, Eric Brochet, Jean-Philippe Labbé, Jean-Pol Depoix, Ulrik Hvass, Alec Vahanian, Noa Holoshitz, Damien Kenny, Ziyad M Hijazi.   

Abstract

BACKGROUND: A 64-year-old female with rheumatic heart disease and multiple prior valve replacements presented with progressive oedema, ascites and dyspnoea on exertion. INVESTIGATION: Physical examination, transthoracic echocardiography, intracardiac echocardiography, transoesophageal echocardiography, right heart cathetherisation, computed tomography. DIAGNOSIS: She had a mitral homograft and Physio ring in the tricuspid position, and presented with severe bioprosthetic tricuspid valve stenosis (mean gradient 16 mmHg) and right-sided heart failure. TREATMENT: A transcatheter 26 mm Edwards SAPIEN valve was placed in the tricuspid position, resulting in near normalisation of tricuspid valve gradient. This represents the first report of a combined valve-in-ring (VIR) and valve in a homograft valve (VIV) SAPIEN implantation.

Entities:  

Mesh:

Year:  2013        PMID: 23872655     DOI: 10.4244/EIJV9I3A64

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  1 in total

1.  Transcatheter tricuspid valve-in-valve implantation for very early bioprosthetic tricuspid stenosis secondary to pacemaker lead entrapment: a case report.

Authors:  Muhammad Hamza Saad Shaukat; Julia Stys; Adam Stys; Tomasz Stys
Journal:  Eur Heart J Case Rep       Date:  2022-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.